Skip to main content
. 2017 Jul 31;38(33):2547–2555. doi: 10.1093/eurheartj/ehx352

Figure 2.

Figure 2

Serum VEGF-D protein levels (A), anti-adenoviral titers (B), and anti-VEGF-D titers (C) at baseline (BL) and 6 (D6), 14 (D14) and 90 (D90) days after gene transfer in controls (control) and AdVEGF-DΔNΔC treated patients (AdVEGF-D). Black dots and lines represent mean ± standard deviation. Blue dots represent values of individual patients.